Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy ESSA Pharma stock
Learn how to easily invest in ESSA Pharma stock.
ESSA Pharma Inc is a biotechnology business based in the US. ESSA Pharma shares (EPIX) are listed on the NASDAQ and all prices are listed in US Dollars.
How to buy shares in ESSA Pharma
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – EPIX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
ESSA Pharma stock price (NASDAQ: EPIX)Use our graph to track the performance of EPIX stocks over time.
ESSA Pharma shares at a glance
|Latest market close||$1.79|
|52-week range||$1.66 - $14.88|
|50-day moving average||$2.71|
|200-day moving average||$6.36|
|Wall St. target price||$23.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.87|
Buy ESSA Pharma shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy ESSA Pharma stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
ESSA Pharma price performance over time
|1 week (2022-09-23)||2.29%|
|1 month (2022-09-01)||-29.80%|
|3 months (2022-07-01)||-36.52%|
|6 months (2022-03-28)||N/A|
|1 year (2021-10-01)||-78.56%|
|2 years (2020-10-01)||-74.21%|
|3 years (2019-10-01)||3.05|
|5 years (2017-09-29)||517.03%|
ESSA Pharma financials
|Gross profit TTM||$0|
|Return on assets TTM||-12.87%|
|Return on equity TTM||-20.12%|
|Market capitalisation||$75.8 million|
TTM: trailing 12 months
ESSA Pharma share dividends
We're not expecting ESSA Pharma to pay a dividend over the next 12 months.
Have ESSA Pharma's shares ever split?
ESSA Pharma's shares were split on a 1:20 basis on 24 April 2018. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your ESSA Pharma shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for ESSA Pharma shares which in turn could have impacted ESSA Pharma's share price.
ESSA Pharma share price volatility
Over the last 12 months, ESSA Pharma's shares have ranged in value from as little as $1.66 up to $14.88. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ESSA Pharma's is 1.5809. This would suggest that ESSA Pharma's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
ESSA Pharma overview
ESSA Pharma Inc. , a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc. ; Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.
ESSA Pharma in the news
ESSA Pharma Appoints Philip Kantoff to its Board of Directors
Frequently asked questionsWhat percentage of ESSA Pharma is owned by insiders or institutions?
Currently 6.509% of ESSA Pharma shares are held by insiders and 102.472% by institutions. When does the fiscal year end for ESSA Pharma?
ESSA Pharma's fiscal year ends in September. Where is ESSA Pharma based?
ESSA Pharma's address is: 999 West Broadway, Vancouver, BC, Canada, V5Z 1K5 What is ESSA Pharma's ISIN number?
ESSA Pharma's international securities identification number is: CA29668H7085 What is ESSA Pharma's CUSIP number?
ESSA Pharma's Committee on Uniform Securities Identification Procedures number is: 29668H104
More guides on Finder
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
Ask an Expert